Get started

Geron Corporation

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

GERN chart

Key stats

Market capitalization
1.081BUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.34USD
Net income
−141.901MUSD
Revenue
596KUSD
Shares float
456.149M
Beta
1.04

About Geron Corporation

Sector
Health Technology
Industry
Biotechnology
CEO
John A. Scarlett
Website
geron.com
Headquarters
Foster City
Employees (FY)
107
Founded
1990
ISIN
US3741631036
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Ideas

BUY GERON CORP. (GERN)Shares of Geron have been on the retail trader’s radar following a series of news and industry catalysts. The late-stage biopharmaceutical company specializes in developing treatments for hematologic malignancies. At the beginning of the year, the company announced positive top-line results from its
Long
by TraderRahulPal
GERN: Daily VCPSetup: Rocketbase VCP: 5W 39/6 4T RS: 98 The posted chart contains a VCP (volatility contraction pattern). The first label "W" stands for weekly and shows the duration of the entire consolidation. In the middle label, the percentage of contractions is indicated (for example, "15/4"), with 15 repre
Long
by fyntrade
GERN perrfect Double Play Play both side no matter what you make money Covered Call & Sell Put alert GERN - Collect Double Premium over 33% 1: Buy 100 Share at $ 2.06 and Sell $ 2 Sell to Open Call for 20 Jan at $0.55 Cent 2: Sell $1.50 Put (Sell to Open) for 20 Jan for $0.25
Long
by stockpivot
1
GERN Biotechology Penny Stock impending EarningsNASDAQ:GERN Chart showing good uptrend with average directional index and sitting above the cloud, GERN had a micro pullback on Friday and so is now ready for an entry. Resistance @ 3.20 back in 2019; Potential upside 35% or more. $2.5 Strike Expiring 8/19.
Long
by AwesomeAvani
Geron Corporation in recovery. GERNB or X Wave. Recovery within a recovery. This is a reflection using technical analysis + only and we do not consider valuation and macro factors at this stage. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than
Long
by Rykin_Capital
GERN - DIAMOND TOP/BOTTOM - BULLISH MOVEAll, this chart sucks in all honestly, but think we are looking at a reversal here, needs to hold exact level it's at before moving up or may drop down one level bounce and should break out the top. Either way WW this week/next.
Long
by DigitalData

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers